Analysts at Cantor Fitzgerald Reconfirmed their “Buy” rating for Cerus (CERS) with $6.0 Price Objective; Hilltop Holdings Has Lowered By $1.08 Million Its Lattice Semiconductor (LSCC) Position

March 11, 2018 - By Shannon Black

Hilltop Holdings Inc decreased Lattice Semiconductor Corp (LSCC) stake by 71.7% reported in 2017Q3 SEC filing. Hilltop Holdings Inc sold 215,600 shares as Lattice Semiconductor Corp (LSCC)’s stock rose 1.45%. The Hilltop Holdings Inc holds 85,100 shares with $443,000 value, down from 300,700 last quarter. Lattice Semiconductor Corp now has $795.71M valuation. The stock increased 1.42% or $0.09 during the last trading session, reaching $6.45. About 767,364 shares traded. Lattice Semiconductor Corporation (NASDAQ:LSCC) has risen 35.73% since March 11, 2017 and is uptrending. It has outperformed by 19.03% the S&P500.

Among 5 analysts covering Cerus (NASDAQ:CERS), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Cerus has $8 highest and $4.0 lowest target. $5.50’s average target is 12.94% above currents $4.87 stock price. Cerus had 10 analyst reports since August 11, 2015 according to SRatingsIntel. The stock of Cerus Corporation (NASDAQ:CERS) earned “Buy” rating by Cantor Fitzgerald on Wednesday, June 7. BTIG Research maintained Cerus Corporation (NASDAQ:CERS) on Friday, May 26 with “Buy” rating. The rating was downgraded by Wedbush on Thursday, December 17 to “Neutral”. The stock has “Buy” rating by Robert W. Baird on Monday, October 30. The firm has “Buy” rating given on Wednesday, August 19 by BTIG Research. The stock has “Buy” rating by Robert W. Baird on Thursday, November 30. The stock has “Buy” rating by Cantor Fitzgerald on Monday, January 8. The rating was downgraded by Zacks to “Buy” on Tuesday, August 11. Robert W. Baird maintained the stock with “Buy” rating in Wednesday, January 24 report. The company was maintained on Thursday, October 5 by Cowen & Co.

Investors sentiment increased to 1.45 in 2017 Q3. Its up 0.13, from 1.32 in 2017Q2. It increased, as 9 investors sold Cerus Corporation shares while 22 reduced holdings. 11 funds opened positions while 30 raised stakes. 57.26 million shares or 0.28% less from 57.42 million shares in 2017Q2 were reported. 36,000 are held by Marathon Cap Mngmt. Steinberg Global Asset Mgmt has 0.04% invested in Cerus Corporation (NASDAQ:CERS) for 89,200 shares. Schwab Charles has 401,735 shares. Manufacturers Life Ins The stated it has 87,656 shares. Goldman Sachs has invested 0% in Cerus Corporation (NASDAQ:CERS). Moreover, Macquarie Ltd has 0% invested in Cerus Corporation (NASDAQ:CERS) for 230,695 shares. Comml Bank Of Mellon Corporation reported 457,493 shares or 0% of all its holdings. Credit Suisse Ag, Switzerland-based fund reported 146,787 shares. Deutsche Fincl Bank Ag stated it has 1.64 million shares or 0% of all its holdings. Vanguard Group invested in 0% or 4.94M shares. 48,000 were reported by Dekabank Deutsche Girozentrale. Tower Rech Cap Limited Liability Co (Trc) holds 0% of its portfolio in Cerus Corporation (NASDAQ:CERS) for 6,796 shares. Price T Rowe Associates Md stated it has 0% of its portfolio in Cerus Corporation (NASDAQ:CERS). Amalgamated Comml Bank has 0% invested in Cerus Corporation (NASDAQ:CERS). Premier Asset Mngmt Limited Liability Corporation holds 0.08% or 127,487 shares.

The stock increased 1.46% or $0.07 during the last trading session, reaching $4.87. About 2.53 million shares traded or 84.80% up from the average. Cerus Corporation (NASDAQ:CERS) has declined 40.83% since March 11, 2017 and is downtrending. It has underperformed by 57.53% the S&P500.

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company has market cap of $605.90 million. The Company’s INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. It currently has negative earnings. The company??s INTERCEPT Blood Systems for platelets and plasma are designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion.

Hilltop Holdings Inc increased Ishares Tr (CSJ) stake by 24,634 shares to 61,971 valued at $6.53M in 2017Q3. It also upped Ishares Tr (PFF) stake by 14,728 shares and now owns 121,327 shares. Indexiq Etf Tr (MNA) was raised too.

Among 5 analysts covering Lattice Semiconductor (NASDAQ:LSCC), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Lattice Semiconductor had 16 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Lattice Semiconductor Corporation (NASDAQ:LSCC) has “Neutral” rating given on Thursday, November 3 by Robert W. Baird. Craig Hallum downgraded Lattice Semiconductor Corporation (NASDAQ:LSCC) on Thursday, April 14 to “Hold” rating. The firm has “Buy” rating by Jefferies given on Wednesday, October 18. As per Tuesday, August 4, the company rating was downgraded by Zacks. The firm earned “Buy” rating on Wednesday, August 10 by Jefferies. On Monday, July 10 the stock rating was maintained by Jefferies with “Hold”. The stock has “Positive” rating by Susquehanna on Tuesday, September 20. The rating was maintained by FBR Capital on Monday, March 7 with “Outperform”. The company was maintained on Tuesday, September 19 by Robert W. Baird. The stock of Lattice Semiconductor Corporation (NASDAQ:LSCC) earned “Hold” rating by Jefferies on Thursday, June 1.

Investors sentiment decreased to 0.95 in Q3 2017. Its down 0.05, from 1 in 2017Q2. It is negative, as 14 investors sold LSCC shares while 44 reduced holdings. 23 funds opened positions while 35 raised stakes. 98.38 million shares or 0.41% more from 97.99 million shares in 2017Q2 were reported. Advisory Network Lc reported 900 shares stake. Credit Suisse Ag holds 0% of its portfolio in Lattice Semiconductor Corporation (NASDAQ:LSCC) for 181,649 shares. California State Teachers Retirement reported 0% in Lattice Semiconductor Corporation (NASDAQ:LSCC). Pinnacle Assoc Limited accumulated 79,210 shares. Art Advsrs Limited Liability Com invested in 32,700 shares or 0.01% of the stock. Paradigm Cap Incorporated Ny holds 0.24% or 529,000 shares. Tower Lc (Trc) accumulated 8,191 shares. The California-based California Employees Retirement Sys has invested 0% in Lattice Semiconductor Corporation (NASDAQ:LSCC). 6,619 are owned by Zurcher Kantonalbank (Zurich Cantonalbank). Sg Americas Securities Lc invested 0% of its portfolio in Lattice Semiconductor Corporation (NASDAQ:LSCC). American Gru holds 82,332 shares or 0% of its portfolio. Quantbot Technology Ltd Partnership reported 1,200 shares. Marshall Wace Ltd Liability Partnership reported 0.05% in Lattice Semiconductor Corporation (NASDAQ:LSCC). Bnp Paribas Arbitrage Sa accumulated 14,334 shares. Hussman Strategic Advsr, Maryland-based fund reported 400,000 shares.

Analysts await Lattice Semiconductor Corporation (NASDAQ:LSCC) to report earnings on May, 8. They expect $0.03 earnings per share, 0.00% or $0.00 from last year’s $0.03 per share. LSCC’s profit will be $3.70M for 53.75 P/E if the $0.03 EPS becomes a reality. After $-0.02 actual earnings per share reported by Lattice Semiconductor Corporation for the previous quarter, Wall Street now forecasts -250.00% EPS growth.